Therapeutic Area Specialist Oncology - Portugal Norte at Bristol-Myers Squibb

Portugal

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, OncologyIndustries

Requirements

  • Higher education (degree) is mandatory; in health sciences is an advantage
  • Postgraduate education preferred, ideally an MBA from a prestigious business school
  • Experience in sales in the Pharmaceutical Industry, preferably in Oncology
  • High level of proficiency in English
  • Geographical availability in the North, Porto or Coimbra
  • Digital experience or training is an advantage, but not mandatory

Responsibilities

  • Develop and implement sales strategies to achieve business objectives
  • Build and maintain strong relationships with healthcare professionals and stakeholders
  • Provide comprehensive information and support on our therapeutic products
  • Collaborate with cross-functional teams to drive strategic initiatives and business growth
  • Ensure compliance with industry regulations and company policies

Skills

Sales Strategy
Relationship Building
Healthcare Professional Engagement
Product Knowledge
Cross-functional Collaboration
Regulatory Compliance
Pharmaceutical Sales

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI